Shares of Celcuity were significantly higher after the company disclosed positive results from a late-stage trial of its treatment for breast cancer. The stock jumped 52% to $79.03 in premarket ...

The company’s market capitalization stands at $15.59 billion, with the stock trading within its 52-week range of $15.55 to $36.91. Summit’s shares have declined 8.46% over the past week despite the ...

Inhibrx Biosciences shares jumped in premarket trading after the company reported positive trial results for its cancer drug ozekibart, including promising data from expanded use. Shares jumped 62% to ...

Investing.com -- Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) stock jumped 9.5% in Monday premarket trading after the company reported promising efficacy data for its cancer treatment CRB-701 in ...

– 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months with an objective response rate (ORR) of 25% – – Combination studies with RAS(ON) inhibitors ongoing, data ...

Q3 2025 Earnings Call Transcript October 29, 2025 IDEX Corporation beats earnings expectations. Reported EPS is $2.03, ...

Investing.com - BridgeBio Pharma (NASDAQ:BBIO), which has seen its stock surge over 130% in the past year to reach a market capitalization of nearly $12 billion, received a price target increase from ...

The climate crisis is amplifying displacement and making life harder for those already forced to flee. Climate change and displacement are increasingly interconnected. As extreme weather events and ...

Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study Target Current Pediatric Patient in Ongoing Study Has Completely Healed Skin After 9 months of ...

As of the end of June 2025, the most recent reporting period, 117.3 million people had been forced to flee their homes globally due to persecution, conflict, violence, human rights violations or ...